Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

• Egile Nagusiak: Martínez del Prado P (Egilea), Alvarez-López I (Egilea), Domínguez-Fernández S (Egilea), Plazaola A (Egilea), Ibarrondo O (Egilea), Galve-Calvo E (Egilea), Ancizar-Lizarraga N (Egilea), Gutierrez-Toribio M (Egilea), Lahuerta-Martínez A (Egilea), Mar J (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2018-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Purificación Martínez del Prado,1 Isabel Alvarez-López,2,3 Severina Domínguez-Fernández,4 Arrate Plazaola,5 Oliver Ibarrondo,6 Elena Galve-Calvo,1 Nerea Ancizar-Lizarraga,2,3 María Gutierrez-Toribio,4 Ainhara Lahuerta-Martínez,5 Javier Mar6,7 1Medical Oncology Service, Basurto University Hospital, B...